PMID: 9553167May 30, 1998Paper

Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial

European Journal of Nuclear Medicine
H PalmedoA Bischof-Delaloye

Abstract

The aim of the trial was to determine the diagnostic accuracy of scintimmammography with technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) in the detection of primary breast cancer and to verify its clinical usefulness. A total of 246 patients with a suspicious breast mass or positive mammogram were included in this prospective European multicentre trial. At 5 min and 60 min (optional) p.i. two lateral prone images were acquired for 10 min each; 30 min p.i. one anterior image was acquired for 10 min. There were 253 lesions (195 palpable and 58 non-palpable), in respect of which histology revealed 165 cancers and 88 benign lesions. Institutional and blinded read results were correlated to core laboratory histopathology results obtained during excisional biopsy. Diagnostic accuracy for the detection of breast cancer was calculated per lesion. The overall sensitivity and specificity of blinded read scintimammography were 71% and 69%, respectively. For palpable lesions, the sensitivity of blinded read and institutional read scintimammography was 83% and 91%, respectively. Sensitivity was not dependent on the density of the breast tissue. Invasive ductal and invasive lobular cancers showed similar sensitivity. The sensitivity an...Continue Reading

Citations

Feb 26, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Giuliano MarianiNaoyuki Watanabe
Mar 4, 2008·Annals of Nuclear Medicine·Hayato KaidaNaofumi Hayabuchi
Jul 7, 2001·Revista española de medicina nuclear·A YildizM Akaydin
Nov 28, 2002·Nuclear Medicine and Biology·Holger PalmedoHans Jürgen Biersack
Apr 1, 2000·Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T·V IvancevicD L Munz
Aug 2, 2003·Breast Cancer Research and Treatment·Moishe LibermanJohn S Sampalis
Jun 2, 2001·Cancer Biotherapy & Radiopharmaceuticals·A YildizG Dalmaz
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·A AzizK Hayashi
Feb 20, 2002·Clinical Nuclear Medicine·Leonard R Coover, Paul J Malaspina
Jun 29, 2002·Nuclear Medicine Communications·I Khalkhali, E Itti
Jun 29, 2002·Nuclear Medicine Communications·J R Buscombe
Jun 24, 2006·Nuclear Medicine Communications·Rahain Hussain, John R Buscombe
Jul 26, 2012·Clinical Obstetrics and Gynecology·Elizabeth D FeldmanShawna C Willey
Dec 20, 2007·Nuclear Medicine Communications·Sarah Bleichner-PerezMarc Steinling
Jul 1, 2005·Breast Cancer Research : BCR·François Bénard, Eric Turcotte
Nov 21, 2008·AJR. American Journal of Roentgenology·Carrie B HruskaMichael K O'Connor
Mar 24, 2010·Radiology·Mark B WilliamsStanislaw Majewski
May 3, 2013·Medical Physics·Carrie B Hruska, Michael K O'Connor
Jan 15, 2005·Cancer Biotherapy & Radiopharmaceuticals·Concetta De CiccoGiovanni Paganelli
Jun 4, 2013·Seminars in Nuclear Medicine·Suleman Surti
Oct 12, 1999·Radiographics : a Review Publication of the Radiological Society of North America, Inc·D Cyrlak, P M Carpenter
Aug 25, 2004·The Breast : Official Journal of the European Society of Mastology·E FondrinierP Jallet
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·E PratsUNKNOWN SMCSTMS
Jan 27, 2015·Breast Cancer Management·Michael K O'Connor
Jun 10, 2016·Medical Physics·Zaiyang LongMichael K O'Connor
Jan 25, 2005·European Journal of Radiology·Reinhold TilingKlaus Hahn
Nov 28, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G M M GommansJ W D de Waard
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·J T KakudaI Khalkhali
Feb 7, 2001·Journal of Computer Assisted Tomography·K YutaniT Nishimura
Mar 24, 2000·Physics in Medicine and Biology·M B WilliamsR Wojcik
Jan 28, 2003·Nuclear Medicine Communications·K Y MaundaJ B Bomanji
Dec 21, 2002·Clinical Nuclear Medicine·Ilknur AkErkan Vardareli
Jan 1, 2010·Experimental and Therapeutic Medicine·Sonia Marta MoriguchiGilberto Uemura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.